SONELOKIMAB

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:18:55 UTC 2023` Edited by `admin` on `Sat Dec 16 14:18:55 UTC 2023`
Protein Type	NANOBODY
Protein Sub Type
Sequence Origin	CAMEL
Sequence Type	COMPLETE
Record UNII	LEN0OCZ4SH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

M-1095

Preferred Name

English

SONELOKIMAB

Official Name

English

sonelokimab [INN]

Common Name

English

M-1095 (ANTI-INTERLEUKIN (IL)-17A/F SINGLE-DOMAIN ANTIBODY)

Common Name

English

ALX-0761

Code

English

ALX0761

Code

English

IMMUNOGLOBULIN G, ANTI-(HUMAN INTERLEUKIN 17F) (HUMAN-LAMA GLAMA NANOBODY CLONE IL17MS3063 .GAMMA.-CHAIN V-D-J REGION FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 9-AMINO ACID LINKER) FUSION PROTEIN WITH IMMUNOGLOBULIN G, ANTI-(HUMAN SERUM ALBUMIN) (

Common Name

English

M1095

Code

English

Code System Code Type Description

INN

11137

Created by admin on Sat Dec 16 14:18:55 UTC 2023 , Edited by admin on Sat Dec 16 14:18:55 UTC 2023

PRIMARY

FDA UNII

LEN0OCZ4SH

Created by admin on Sat Dec 16 14:18:55 UTC 2023 , Edited by admin on Sat Dec 16 14:18:55 UTC 2023

PRIMARY

NCI_THESAURUS

C171838

Created by admin on Sat Dec 16 14:18:55 UTC 2023 , Edited by admin on Sat Dec 16 14:18:55 UTC 2023

PRIMARY

CAS

1414386-05-2

Created by admin on Sat Dec 16 14:18:55 UTC 2023 , Edited by admin on Sat Dec 16 14:18:55 UTC 2023

PRIMARY

From	To
1_22	1_96
1_154	1_228
1_278	1_350

Related Record Type Details


					C4U7R2F9B9

INTERLEUKIN-17F

TARGET -> INHIBITOR


					ZIF514RVZR

ALBUMIN HUMAN

TARGET->LIGAND

Comments:

Binds to human serum albumin for in vivo serum half-life extension.


					R44E6C7B6J

INTERLEUKIN-17A

TARGET -> INHIBITOR

Related Record Type Details


					LEN0OCZ4SH

SONELOKIMAB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL